Drs. Sandy Chang and Kathleen Collins join LIFE LENGTH®s Scientific Advisory Board | Life Length

Drs. Sandy Chang and Kathleen Collins join LIFE LENGTH®s Scientific Advisory Board

Drs. Sandy Chang and Kathleen Collins join LIFE LENGTH<span class="superindice">®</span>s Scientific Advisory Board

06 Mar Drs. Sandy Chang and Kathleen Collins join LIFE LENGTH®s Scientific Advisory Board

Life Length, the world’s leading telomere testing and services company, announced that Drs. Sandy Chang and Kathleen Collins have joined its Scientific Advisory Board (“SAB”). Stephen J. Matlin, CEO, Life Length, noted, “We are delighted to welcome these worldrenowned telomere and telomerase experts to Life Length’s SAB. They will help advance our global leadership. Dr. Chang is especially well known for pioneering work in understanding how telomere binding proteins protect chromosome ends from engaging DNA damage response. Dr. Collins has led the way in reconstituting recombinant telomerase complexes and demonstrating the significance of individual differences in telomere length on human health span.” Dr. Sandy Chang is currently Associate Professor and Associate Director of Molecular Diagnostics, Department of Laboratory Medicine, Yale University School of Medicine, having received numerous awards including those from the Howard Hughes Medical Institute, the Ellison Medical Foundation, the Sidney Kimmel Foundation for Cancer Research, and the Ellis Benson Award from the Academy of Clinical Laboratory Physicians and Scientists. Dr. Kathleen Collins is Professor of Molecular and Cell Biology at the University of California, Berkeley. Her awards include a Burroughs Wellcome Fund Award in Pharmacological Sciences, Early Career Life Scientist Award from The American Society for Cell Biology, and University of California Berkeley Miller Professorship. In addition to Drs. Chang and Collins, the Life Length SAB includes Dr. María A. Blasco, Director, Spanish National Cancer Research Centre; Dr. Jerry W. Shay, Vice Chairman, Department of Cell Biology, The University of Texas Southwestern Medical Center, Dallas; Dr. William H. Andrews, founder, President and CEO, Sierra Sciences, that focuses exclusively on finding drugs that will transiently induce expression of endogenous telomerase in human cells; and Dr. Mark Rosenberg, MD, President, The Institute for Healthy Aging.

No Comments

Post A Comment